Heart Failure (Treatment)

Gene Therapy May Be Able To Reverse Heart Failure

Published in Gene Therapy Weekly, January 13th, 2000

Researchers from the Massachusetts General Hospital (MGH) have, for the first time, shown that gene therapy may be able to reverse heart failure, one of the major causes of death and disability in North America and Europe.

In their study appearing in the December 7, 1999, issue of Circulation, the team from the MGH Cardiovascular Research Center (CVRC), along with collaborators from Boston University Medical Center, Massachusetts, USA, and Imperial College in London, UK, reported delivering additional copies of a gene called SERCA2a to muscle cells from failing human hearts. Cells that incorporated the gene and produced elevated levels of its protein began to function...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2000-01-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry